Milk Specialties Global begins lactoferrin production
The project, which will be completed in May, is in support of ongoing customer partnerships and to align with their future supply chain needs.
“The research around the health and immune benefits of lactoferrin is very compelling,” said David Lenzmeier, CEO of Milk Specialties Global.
“We recognize that consumers are becoming more health conscious and we make it a priority to stay in tune with our customers. We are simply excited to play a key role in the development of the next generation of health-focused products.”
Lactoferrin is a protein fraction occurring naturally in whey protein. Lactoferrin comprises only a tiny portion of the overall whey protein but Milk Specialties Global said it offers health benefits when concentrated. There is a growing body of research around the benefits of concentrated lactoferrin for all life stages including enhanced immune system support, promotion of “good” prebiotic bacteria for positive gut health and improved iron status.
Recent studies have brought lactoferrin’s antiviral properties to the forefront, demonstrating it can favorably influence human cell response to Covid-19 infection.
“Milk and its components are such an incredible canvas to create innovative products,” said Tom Benson, executive vice president at Milk Specialties Global.
“As the world is becoming more health focused, we saw an opportunity to diversify our portfolio, deepen our commitment to customers and grow with them in the future.”
Lactoferrin is part of Milk Specialties’ NutriPRO family of products and comes in a wide range of concentration options – from 0.15% purity up to 95% purity. Lactoferrin can be used in a range of applications. Along with being a core ingredient in infant formula, it is suitable for health supplements, medical nutrition products, ready-to-mix drinks and functional foods.
